MEI Pharma, Inc. (MEIP)

[bladerunner1717]

Hey MC5,

Always hard to predict in biotech; so many things can go wrong.

By the end of this year, MEIP will have two drugs in pivotal trials, Pracinostat in MDS and AML, and ME-401 in follicular lymphoma. The first is partnered with a very good Swiss Pharmaceutical, Helsinn, the second drug is proprietary. The company now has a solid cash position to advance ME-401 and the rest of the pipeline. Helsinn is picking up the tab for the Pracinostat trials.

An oncologist friend of says that ME-401 is a best-in-class drug and, if that is true, I expect a partnership on the drug, but hard to say when.

The management team seems solid to me.

Even with the recent run-up, I think MEIP is still undervalued.

Good luck.

Bladerunner